Literature DB >> 5521364

Pivampicillin, a new orally active ampicillin ester.

W von Daehne, W O Godtfredsen, K Roholt, L Tybring.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5521364

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother (Bethesda)


× No keyword cloud information.
  17 in total

1.  New broad-spectrum penicillins.

Authors:  H C Neu
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  Serum concentrations of ampicillin and probenecid and ampicillin excretion after repeated oral administration of a pivampicillin-probenecid salt (MK-356).

Authors:  H G Kampffmeyer; I Hartmann; H Metz; G O Breault; H R Skeggs; A E Till; L Weidner
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

3.  Gastrointestinal absorption and metabolism of two 35S-labelled ampicillin esters.

Authors:  A Swahn
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953

Review 4.  Influence of food and diet on gastrointestinal drug absorption: a review.

Authors:  P G Welling
Journal:  J Pharmacokinet Biopharm       Date:  1977-08

Review 5.  Newer beta-lactam antibiotics.

Authors:  J M Hamilton-Miller; W Brumfitt
Journal:  Infection       Date:  1974       Impact factor: 3.553

6.  Pivampicillin treatment of urogenital infections in gynaecological patients. Clinical evaluation.

Authors:  O Jordheim
Journal:  Infection       Date:  1974       Impact factor: 3.553

7.  Pivampicillin hydrochloride in uncomplicated gonorrhoea.

Authors:  L Förström; A Lassus
Journal:  Br J Vener Dis       Date:  1972-12

8.  Amoxycillin in the treatment of gonorrhoea.

Authors:  R R Willcox
Journal:  Br J Vener Dis       Date:  1972-12

9.  Investigations on pivampicillin treatment in newborns and infants.

Authors:  W Marget; F Daschner; K Unertl
Journal:  Infection       Date:  1973       Impact factor: 3.553

10.  Solubilization and stabilization of a benzylpenicillin chemical delivery system by 2-hydroxypropyl-beta-cyclodextrin.

Authors:  E Pop; T Loftsson; N Bodor
Journal:  Pharm Res       Date:  1991-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.